Alixorexton Shows Mixed Efficacy in Mid-Stage Narcolepsy Type 2 Trial

November 13, 2025

Marketing Authorization Granted for AbbVie’s Migraine Therapy Aquipta

September 5, 2023

Algernon Pharmaceuticals Starts both Repirinast Production and CKD Research Program

March 3, 2022

Must Read

How Are Macroeconomic Conditions Impacting Pharma and Biotech Funding?

April 22, 2026

Top 10 Biotech Podcasts Every Professional Should Listen To in 2026

April 22, 2026

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

April 22, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

AstraZeneca Reports Phase 3 MIRANDA Trial Success for Tozorakimab in COPD

Travere’s Filspari becomes the first FDA-approved medication for FSGS

IDEAYA and Servier Report Phase 2/3 Trial Success for Darovasertib Combination in Uveal Melanoma

Revolution Meets Key Survival Goals With RAS Inhibitor In Important Trial

Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

BMS and Bain Capital Launch Beeline Medicines with Autoimmune Pipeline Led by Afimetoran

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

How Are Macroeconomic Conditions Impacting Pharma and Biotech Funding?

Top 10 Biotech Podcasts Every Professional Should Listen To in 2026

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

Top 10 Life Sciences News Platforms for Industry Insights in 2026

Commercial

Is Biogen’s Alzheimer’s drug worth $56K? Experts say $8400 and raise questions about efficacy

Editor Picks

Alixorexton Shows Mixed Efficacy in Mid-Stage Narcolepsy Type 2 Trial

Marketing Authorization Granted for AbbVie’s Migraine Therapy Aquipta

Algernon Pharmaceuticals Starts both Repirinast Production and CKD Research Program

Must Read

How Are Macroeconomic Conditions Impacting Pharma and Biotech Funding?

Top 10 Biotech Podcasts Every Professional Should Listen To in 2026

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

Hot Topics

About Us

Follow Us